400 related articles for article (PubMed ID: 1464614)
1. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
Houck KA; Leung DW; Rowland AM; Winer J; Ferrara N
J Biol Chem; 1992 Dec; 267(36):26031-7. PubMed ID: 1464614
[TBL] [Abstract][Full Text] [Related]
2. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
[TBL] [Abstract][Full Text] [Related]
3. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.
Cohen T; Gitay-Goren H; Sharon R; Shibuya M; Halaban R; Levi BZ; Neufeld G
J Biol Chem; 1995 May; 270(19):11322-6. PubMed ID: 7744769
[TBL] [Abstract][Full Text] [Related]
4. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.
Park JE; Keller GA; Ferrara N
Mol Biol Cell; 1993 Dec; 4(12):1317-26. PubMed ID: 8167412
[TBL] [Abstract][Full Text] [Related]
5. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
Soker S; Fidder H; Neufeld G; Klagsbrun M
J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
[TBL] [Abstract][Full Text] [Related]
7. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.
Houck KA; Ferrara N; Winer J; Cachianes G; Li B; Leung DW
Mol Endocrinol; 1991 Dec; 5(12):1806-14. PubMed ID: 1791831
[TBL] [Abstract][Full Text] [Related]
8. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.
Gitay-Goren H; Soker S; Vlodavsky I; Neufeld G
J Biol Chem; 1992 Mar; 267(9):6093-8. PubMed ID: 1556117
[TBL] [Abstract][Full Text] [Related]
9. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
[TBL] [Abstract][Full Text] [Related]
10. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
[TBL] [Abstract][Full Text] [Related]
11. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.
Keyt BA; Berleau LT; Nguyen HV; Chen H; Heinsohn H; Vandlen R; Ferrara N
J Biol Chem; 1996 Mar; 271(13):7788-95. PubMed ID: 8631822
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and its receptors.
Neufeld G; Tessler S; Gitay-Goren H; Cohen T; Levi BZ
Prog Growth Factor Res; 1994; 5(1):89-97. PubMed ID: 7515293
[TBL] [Abstract][Full Text] [Related]
13. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.
Tessler S; Rockwell P; Hicklin D; Cohen T; Levi BZ; Witte L; Lemischka IR; Neufeld G
J Biol Chem; 1994 Apr; 269(17):12456-61. PubMed ID: 8175651
[TBL] [Abstract][Full Text] [Related]
14. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect.
Plouët J; Moro F; Bertagnolli S; Coldeboeuf N; Mazarguil H; Clamens S; Bayard F
J Biol Chem; 1997 May; 272(20):13390-6. PubMed ID: 9148962
[TBL] [Abstract][Full Text] [Related]
15. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix.
Poltorak Z; Cohen T; Sivan R; Kandelis Y; Spira G; Vlodavsky I; Keshet E; Neufeld G
J Biol Chem; 1997 Mar; 272(11):7151-8. PubMed ID: 9054410
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.
Myoken Y; Kayada Y; Okamoto T; Kan M; Sato GH; Sato JD
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5819-23. PubMed ID: 1712106
[TBL] [Abstract][Full Text] [Related]
17. Unique properties of 189 amino acid isoform of vascular endothelial growth factor in tumorigenesis.
Tomii Y; Yamazaki H; Sawa N; Ohnishi Y; Kamochi J; Tokunaga T; Osamura Y; Sadahiro S; Kijima H; Abe Y; Ueyama Y; Tamaoki N; Nakamura M
Int J Oncol; 2002 Dec; 21(6):1251-7. PubMed ID: 12429975
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney.
Simon M; Gröne HJ; Jöhren O; Kullmer J; Plate KH; Risau W; Fuchs E
Am J Physiol; 1995 Feb; 268(2 Pt 2):F240-50. PubMed ID: 7864162
[TBL] [Abstract][Full Text] [Related]
19. Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells.
Ferrara N; Leung DW; Cachianes G; Winer J; Henzel WJ
Methods Enzymol; 1991; 198():391-405. PubMed ID: 1857232
[No Abstract] [Full Text] [Related]
20. The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases.
Poltorak Z; Cohen T; Neufeld G
Herz; 2000 Mar; 25(2):126-9. PubMed ID: 10829252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
